DIMENSIONAL FUND ADVISORS LP - FATE THERAPEUTICS INC ownership

FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 60 filers reported holding FATE THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
DIMENSIONAL FUND ADVISORS LP ownership history of FATE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,516,237
+55.6%
715,149
+249.3%
0.00%
Q2 2023$974,536
-51.1%
204,726
-41.4%
0.00%
-100.0%
Q1 2023$1,991,506
+35692.7%
349,529
-36.6%
0.00%
-50.0%
Q4 2022$5,564
-99.9%
551,469
+130.1%
0.00%0.0%
Q3 2022$5,371,000
-18.9%
239,682
-10.3%
0.00%0.0%
Q2 2022$6,620,000
-56.1%
267,166
-31.3%
0.00%
-60.0%
Q1 2022$15,088,000
-37.8%
389,116
-6.1%
0.01%
-28.6%
Q4 2021$24,254,000
+28.2%
414,477
+29.9%
0.01%
+16.7%
Q3 2021$18,912,000
+70.1%
319,069
+149.1%
0.01%
+50.0%
Q2 2021$11,117,000
+107.5%
128,065
+97.7%
0.00%
+100.0%
Q1 2021$5,357,000
+82.1%
64,762
+100.1%
0.00%
+100.0%
Q4 2020$2,942,000
+276.7%
32,358
+42.1%
0.00%
Q2 2020$781,000
+54.3%
22,7710.0%0.00%
Q1 2020$506,000
+7.7%
22,771
-5.1%
0.00%
Q4 2019$470,000
+76.7%
24,000
+2.1%
0.00%
Q2 2018$266,000
+16.2%
23,5000.0%0.00%
Q1 2018$229,000
+59.0%
23,5000.0%0.00%
Q4 2017$144,000
+54.8%
23,5000.0%0.00%
Q3 2017$93,000
+22.4%
23,5000.0%0.00%
Q2 2017$76,00023,5000.00%
Other shareholders
FATE THERAPEUTICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 3,379,064$131,006,00024.77%
Redmile Group, LLC 12,957,222$502,351,00015.68%
Grosvenor Holdings, L.L.C. 1,037,256$40,214,0007.85%
Casdin Capital, LLC 3,400,000$131,818,0005.91%
Ally Bridge Group (NY) LLC 181,500$7,037,0005.22%
DAFNA Capital Management LLC 500,930$19,421,0005.06%
Deep Track Capital, LP 2,000,000$77,540,0004.97%
Artal Group S.A. 2,000,000$77,540,0003.25%
Tri Locum Partners LP 190,345$7,380,0002.88%
ARK Investment Management 10,988,182$426,012,0001.78%
View complete list of FATE THERAPEUTICS INC shareholders